Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy

Outcomes Following Image-Guided Therapy for Hepatic Malignancies

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00482586

Enrollment

137

Registered

2007-06-05

Start date

2003-10-31

Completion date

2015-04-30

Last updated

2015-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cancer, Metastatic Cancer

Keywords

adult primary liver cancer, liver metastases

Brief summary

RATIONALE: Gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy may help the study of cancer in the future. PURPOSE: This clinical trial is gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy.

Detailed description

OBJECTIVES: * Develop a data repository for clinical and health-related quality of life outcome measures in patients with hepatic malignancies treated with image-guided therapies. OUTLINE: This is a pilot, prospective, longitudinal study. Patients complete a standard questionnaire assessing health-related quality of life at baseline, during routine follow-up care after image-guided therapy, and then annually thereafter. Health and disease status and the development of other illnesses are assessed by medical record review. PROJECTED ACCRUAL: Not specified

Interventions

OTHERmedical chart review

Review the medical charts of patients with hepatic neoplasms who undergo Image-guided Therapy.

OTHERquestionnaire administration

Patients with hepatic neoplasms who undergo Image-guided Therapy

PROCEDUREquality-of-life assessment

Patients with hepatic neoplasms who undergo Image-guided Therapy

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

DISEASE CHARACTERISTICS: * Undergoing concurrent image-guided therapy for hepatic malignancies using any of the following imaging techniques: * X-ray * Ultrasound * MRI * CT scan * Nuclear medicine imaging PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Design outcomes

Primary

Measure	Time frame
Development of a data repository for clinical outcome measures by conducting a medical record review at baseline, during routine follow-up after image-guided therapy, and then annually thereafter	one year
Development of a data repository for health-related quality of life outcome measures by administering the Medical Outcomes Study Short Form questionnaire at baseline, during routine follow-up after image-guided therapy, and then annually thereafter	one year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026